These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 5080965)

  • 1. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary and secondary resistance in 257 cases of pulmonary tuberculosis from 1964 to 1966 at the Pneumology Service in Poitiers].
    Rautlin de la Roy Y DE; Beauchant G; Brisou J; Dussouil P; Charpentier
    Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1054-9. PubMed ID: 4317484
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proceedings: Current status and perspectives of tuberculosis chemotherapy in Algeria].
    Larbaoui D; Chaulet P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):139-46. PubMed ID: 4491711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness and problems of the treatment of tuberculosis under the environmental conditions of an underdeveloped country].
    Henneghien C; Ballez C; Horvath K; el-Fassi M
    Acta Tuberc Pneumol Belg; 1969; 60(6):821-32. PubMed ID: 5397018
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of early detected destructive pulmonary tuberculosis].
    Anfilof'eva OIu; fedotova ZN
    Probl Tuberk; 1974; (12):38-41. PubMed ID: 4445134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
    Rastvortseva TN
    Probl Tuberk; 1971; 49(6):31-4. PubMed ID: 5117826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary tuberculosis in aged patients: therapeutic methods and results (121 cases)].
    Petitjean R; Burghard G; Chauvet J; Weitzenblum S
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):580-6. PubMed ID: 5510325
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
    Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M; Banaszkiewicz H; Czerwiński Z; Królikowska H; Krahowska M; Malecki S; Pezińska Z; Pilch Z; Przemyska B; Szustrowa I; Wardowa A
    Gruzlica; 1973 Jul; 41(7):755-64. PubMed ID: 4730976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reasons for failures in chemotherapy of tuberculosis].
    Dissmann E
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):17-24. PubMed ID: 5728639
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changing picture of tuberculosis during a decade].
    Tveit J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(12):866-8. PubMed ID: 5554775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.